Jeffrey B. Mirviss Net Worth

Track Major Insider Updates On X/Twitter

Last Updated: 2 days, 3 hours ago

Jeffrey B. Mirviss has an estimated net worth of at least $19.3 million*, as of Feb. 19, 2025. They own 33,129 shares of BSX stock. They have sold 264,550 shares of BSX stock since 2021, for an estimated $15.7 million.

Jeffrey B. Mirviss $BSX SEC Form 4 Insider Trading

Jeffrey B. Mirviss has filed a total of 22 insider trades in $BSX since 2021. Their most recent trade was a sale of 1,510 shares, made on Feb 19, 2025. Their largest trade was a sale of 63,802 shares, made on May 29, 2024. We estimate that they now own 33,129 shares of $BSX, worth an estimated $3.6 million.

Insider Trading at $BSX

There have been a total of 168 insider trades reported at $BSX since 2021, with 25,050 shares purchased and 4.5 million shares sold. The most active insider traders in $BSX stock have been Wendy Carruthers, Jeffrey B. Mirviss, and Michael F Mahoney. The most recent trade was a sale of 3,303 shares reported by John Bradley Sorenson (EVP, Global Operations), made on Feb 19, 2025.

History of Insider Stock Trades by Jeffrey B. Mirviss

Company Ticker	Purchase / Sale	Shares	Date	Disclosed (EST)
BSX	Sale	1,510	Feb 19, 2025	Feb. 19, 2025, 5:23 p.m.
BSX	Sale	13,022	Feb 12, 2025	Feb. 13, 2025, 5:32 p.m.
BSX	Sale	63,802	May 29, 2024	May 30, 2024, 4:27 p.m.
BSX	Sale	14,506	Mar 18, 2024	March 19, 2024, 4:41 p.m.
BSX	Sale	4,960	Feb 21, 2024	Feb. 22, 2024, 5:19 p.m.
BSX	Sale	15,172	Jan 09, 2024	Jan. 10, 2024, 6:44 p.m.
BSX	Sale	15,000	Jan 04, 2024	Jan. 5, 2024, 5:53 p.m.
BSX	Sale	353	Dec 06, 2023	Dec. 7, 2023, 5:10 p.m.
BSX	Sale	4,657	Aug 29, 2023	Aug. 30, 2023, 4:10 p.m.
BSX	Sale	13,971	Aug 28, 2023	Aug. 30, 2023, 4:10 p.m.
BSX	Sale	4,903	Apr 05, 2023	April 6, 2023, 4:26 p.m.
BSX	Sale	4,903	Mar 30, 2023	March 31, 2023, 4:29 p.m.
BSX	Sale	1,409	Feb 16, 2023	Feb. 21, 2023, 5:19 p.m.
BSX	Sale	2,061	Feb 17, 2023	Feb. 21, 2023, 5:19 p.m.
BSX	Sale	6,751	Jan 04, 2023	Jan. 4, 2023, 5:21 p.m.
BSX	Sale	11,080	Dec 12, 2022	Dec. 13, 2022, 5:49 p.m.
BSX	Sale	41,032	Dec 09, 2022	Dec. 12, 2022, 5:26 p.m.
BSX	Sale	9,645	Apr 20, 2022	April 21, 2022, 4:26 p.m.
BSX	Sale	10,989	Apr 19, 2022	April 20, 2022, 4:52 p.m.
BSX	Sale	11,236	Mar 22, 2022	March 23, 2022, 4:20 p.m.
BSX	Sale	6,840	Jan 04, 2022	Jan. 4, 2022, 8 p.m.
BSX	Sale	6,748	Jul 27, 2021	July 26, 2021, 8 p.m.

$BSX Executives and Stock Owners with Insider Trades

Wendy Carruthers, EVP, Human Resources
Jeffrey B. Mirviss, EVP&Pres, Periph Intervent
Michael F Mahoney, Chairman, President & CEO
Daniel J. Brennan, EVP and CFO
Arthur C Butcher, EVP& Grp Pres, MedSurg & APAC
Joseph Michael Fitzgerald, EVP & Group Pres, Cardiology
John Bradley Sorenson, EVP, Global Operations
Wendy Carruthers, SVP, Human Resources
David A Pierce, EVP Pres MedSurg
Jodi Euerle Eddy, SVP, Chief Info & Digital Off.
Eric Francis Yves Thepaut, EVP & Pres, Eur, Mid-East, Afr
Jonathan Monson, VP, Global Controller and CAO
Vance R Brown, SVP, GC and Corp. Secretary
Arthur C Butcher, EVP&Pres, Asia Pacific
Meghan Scanlon, SVP,Pres,Urology Pelvic Health
Scott Olson, SVP & Pres, CRM, Diagnostics
Scott Olson, SVP & Pres, Rhythm Management
Jonathan Monson, SVP, Global Controller and CAO
Ian T Meredith, EVP Global Chief Med Officer
John Bradley Sorenson, SVP, Global Supply Chain
Emily Woodworth, SVP, Global Controller and CAO
Joseph Michael Fitzgerald, EVP & Pres, Interven Cardio
Maulik Nanavaty, SVP & Pres, Neuromodulation
Edward F Mackey, EVP, Operations

*This is only based off of information found in SEC filings, and may not reflect actual net worth. There may also be inaccuracies due to privately holdings filing errors, parsing errors, accidental double-counting of shares, incorrect classification of indirectly owned shares, sales prior to dataset start date, or any other number of issues.